Waleed Haso

Waleed Haso is a seasoned professional with extensive expertise in cancer immunotherapy, specializing in chimeric antigen receptor (CAR) engineered T cells.

With an in-depth understanding of genome editing techniques, he is skilled in utilizing CRISPR in primary T cells.

Additionally, Waleed has a foundational knowledge of bioinformatics programming and data analysis, particularly utilizing Perl and R.

He pursued his education with an MS in Biotechnology, focusing on Molecular Targets and Drug Discovery at The Johns Hopkins University, and a B.S. in Bioinformatics from Ramapo College of New Jersey.

Waleed Haso has held positions at reputable organizations, including Senior Research Scientist at Kite Pharma, Principal Scientist at Mustang Bio, Scientist I at MedImmune, Molecular Immunology Associate at Lentigen Technology at Miltenyi Biotec, Scientist II at Novartis Institutes for BioMedical Research, and CRTA Research Fellow at National Cancer Institute.